Ivan J. Stone
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 2%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
- Oncology 20
- HER2/EGFR in Cancer Research 13
- CAR-T cell therapy research 6
- Peptidase Inhibition and Analysis 4
-
- Monoclonal and Polyclonal Antibodies Research 19
- Co-authors
- Lori Westendorf (8 shared papers)Iqbal S. Grewal (11 shared papers)Peter D. Senter (10 shared papers)Kristine A. Gordon (6 shared papers)Robert P. Lyon (8 shared papers)Che‐Leung Law (13 shared papers)Ezogelin Oflazoglu (5 shared papers)Charlotte F. McDonagh (6 shared papers)
- Journals
- Blood (12 papers)Molecular Cancer Therapeutics (6 papers)Cancer Research (4 papers)Nature Biotechnology (1 paper)The Journal of General Psychology (1 paper)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Ivan J. Stone
33 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 75
- Radiology, Nuclear Medicine and Imaging 970
- Oncology 1.1k
- Hematology 158
- Immunology 297
- Genetics 116
Countries citing papers authored by Ivan J. Stone
This map shows the geographic impact of Ivan J. Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan J. Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan J. Stone more than expected).
Fields of papers citing papers by Ivan J. Stone
This network shows the impact of papers produced by Ivan J. Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan J. Stone. The network helps show where Ivan J. Stone may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan J. Stone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 309 | |
| 2 | 2006 | 202 | |
| 3 | 2006 | 146 | |
| 4 | 2016 | 120 | |
| 5 | 2007 | 103 | |
| 6 | 2008 | 99 | |
| 7 | 2006 | 92 | |
| 8 | 2008 | 81 | |
| 9 | 2008 | 72 | |
| 10 | 2019 | 68 | |
| 11 | 2009 | 68 | |
| 12 | 2008 | 67 | |
| 13 | 2017 | 58 | |
| 14 | 2016 | 51 | |
| 15 | 2017 | 38 | |
| 16 | 2017 | 21 | |
| 17 | 2015 | 19 | |
| 18 | 2016 | 15 | |
| 19 | 2005 | 14 | |
| 20 | 2011 | 14 |
About Ivan J. Stone
Ivan J. Stone is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Pathology and Forensic Medicine and Hematology, having authored 33 papers that have together received 1.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (19 papers), HER2/EGFR in Cancer Research (13 papers), Lymphoma Diagnosis and Treatment (9 papers), Glycosylation and Glycoproteins Research (7 papers), CAR-T cell therapy research (6 papers), Multiple Myeloma Research and Treatments (5 papers), Cancer therapeutics and mechanisms (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (970 citations), Oncology (1.1k citations), Hematology (158 citations), Immunology (297 citations) and Genetics (116 citations). Ivan J. Stone has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Lori Westendorf, Iqbal S. Grewal, Peter D. Senter, Kristine A. Gordon, Robert P. Lyon, Che‐Leung Law, Ezogelin Oflazoglu, Charlotte F. McDonagh, Scott C. Jeffrey and Stephen C. Alley. Their work appears in journals such as Blood, Molecular Cancer Therapeutics, Cancer Research, Nature Biotechnology and The Journal of General Psychology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.